Glenmark Pharmaceuticals Limited (GLENMARK.NS)

Home
GLENMARK.NS
Financials

1666.5 (INR) • At close November 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1	2011 Q4	2011 Q3
Revenue Numbers are in millions	32,441.86	30,629.52	24,602.9	31,606.87	33,361.47	33,006.13	33,922.37	33,124.86	27,200.97	29,611.52	31,414.72	31,254.26	29,461.48	28,298.89	27,587.36	29,081.18	23,092.83	27,112.73	26,386.2	27,637.31	22,836.04	25,260.82	25,097.97	25,398.57	21,293.66	22,478.93	21,715.05	22,234.4	23,293.94	24,244.14	24,629.53	21,731.83	18,832.07	22,890.55	17,642.78	18,951.65	16,424.2	17,537.92	16,921.12	16,715.34	14,778.19	16,214.94	16,012.23	14,630.06	12,378.82	13,354.85	13,812.59	12,551.91	10,404.07	10,658.56	10,310.86
Cost of Revenue Numbers are in millions	19,383.11	18,478.2	10,322.58	11,977.84	12,279.99	11,921.1	11,660.68	11,667.29	10,120.46	11,052.9	10,718.94	11,435.53	11,389.69	9,833.59	9,113.67	10,407.18	8,083.66	10,440.49	9,263.38	9,861.49	8,101.02	9,059.47	8,620.14	8,808.09	7,587.97	7,843.03	7,815.71	7,512.47	7,214.46	7,769.48	5,990.39	6,147.55	6,235.84	7,336.87	5,280.77	5,974.52	5,021.37	3,817.76	5,559.82	5,494.84	4,471.95	4,830.1	5,373.09	4,868.58	4,049.88	3,770	4,677.16	4,425.78	3,663.08	4,108.96	3,702.51
Gross Profit Numbers are in millions	13,058.75	12,151.32	14,280.32	19,629.03	21,081.48	21,085.03	22,261.69	21,457.57	17,080.51	18,558.62	20,695.78	19,818.73	18,071.79	18,465.3	18,473.69	18,674	15,009.17	16,672.24	17,122.82	17,775.82	14,735.02	16,201.35	16,477.83	16,590.48	13,705.69	14,635.9	13,899.34	14,721.93	16,079.48	16,474.66	18,639.14	15,584.28	12,596.23	15,553.68	12,362.01	12,977.13	11,402.83	13,720.16	11,361.3	11,220.5	10,306.24	11,384.84	10,639.14	9,761.48	8,328.94	9,584.85	9,135.43	8,126.13	6,740.99	6,549.6	6,608.35
Gross Profit Ratio Numbers are in millions	0.403	0.397	0.58	0.621	0.632	0.639	0.656	0.648	0.628	0.627	0.659	0.634	0.613	0.653	0.67	0.642	0.65	0.615	0.649	0.643	0.645	0.641	0.657	0.653	0.644	0.651	0.64	0.662	0.69	0.68	0.757	0.717	0.669	0.679	0.701	0.685	0.694	0.782	0.671	0.671	0.697	0.702	0.664	0.667	0.673	0.718	0.661	0.647	0.648	0.614	0.641
Reseach & Development Expenses Numbers are in millions	0	0	0	0	0	3,363	2,760	3,300	2,979	12,787.08	3,030	3,290	2,837	3,040	0	0	0	13,205.12	0	0	0	14,480.26	0	0	0	12,251.33	0	0	0	12,622.33	0	0	0	8,175.9	0	0	0	6,014.42	0	0	0	5,998.06	0	0	0	4,115.59	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	0	0	544.88	0	0	0	6,130.33	0	0	0	1,282.45	0	0	0	5,623.64	0	0	0	5,971.6	0	0	0	4,642.73	0	0	0	3,847.4	0	0	0	3,495.89	0	0	0	2,548.91	0	0	0	921.04	0	0	0	815.98	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	5,282.71	0	0	0	4,348.51	0	0	0	4,286.51	0	0	0	5,697.63	0	0	0	7,151.33	0	0	0	6,430.35	0	0	0	7,193.31	0	0	0	5,429.75	0	0	0	3,422.44	0	0	0	4,436.38	0	0	0	4,677.08	0	0	0	0	0
SG&A Numbers are in millions	8,354.51	8,621.26	9,300.55	8,144.3	7,294.05	5,827.59	6,455.5	5,259.46	6,363.67	10,478.84	5,859.91	6,873.29	3,722.28	5,568.96	5,966.43	7,002.54	5,096.06	11,321.27	5,572.46	6,866	4,866.9	13,122.93	5,030.81	6,058.95	4,525.09	11,073.08	4,659.42	5,572.3	3,843.96	11,040.71	4,016.81	4,823.98	3,719.87	8,925.64	3,448.9	3,984.03	2,860.17	5,971.35	3,165.25	3,552.95	2,764.05	11,921.74	2,734.66	2,644.7	2,108.19	10,510.76	2,123.74	2,015.6	0	0	0
Other Expenses Numbers are in millions	314.92	7,731.65	454.1	16.97	208.72	-402.13	764.15	974.28	1,831.55	93.63	138.95	-130.72	586.49	51.42	150.9	-318.81	585.14	-991.64	329.63	808.25	16.69	-1,422.93	-1,090.24	1,398.62	1,382.16	11,568.57	321.57	331.5	336.08	327.69	720.55	509.26	598.45	176.21	140.18	141.98	128.28	220.21	91.95	91.74	91.21	35.76	5.29	3.74	3.61	7,512.42	6,238.69	3.83	2.67	5,996.65	5,703.65
Operating Expenses Numbers are in millions	8,354.51	8,621.26	17,837.55	16,420.72	16,315.86	16,500.68	17,682	16,799.02	14,232.05	15,175.01	14,953.56	15,148.94	13,466.72	13,589.62	14,324.95	14,186.55	11,360.71	13,266.39	13,782.06	14,213.35	12,223.21	15,211.31	13,066.43	13,123.09	11,030.7	11,568.57	12,120.85	11,746.64	11,366.12	13,722.07	12,352.7	12,395.01	9,408.19	13,377.02	9,409.99	9,786.96	8,472.05	11,767.66	9,429.89	8,600.35	7,590.18	10,473.81	7,554.9	7,079.61	6,170.11	7,512.42	6,238.69	5,671.8	5,341.2	5,996.65	5,703.65
Operating Income Numbers are in millions	4,704.24	3,530.06	-3,103.13	3,225.28	4,765.62	4,182.22	5,343.84	5,632.83	2,848.46	2,788.69	5,881.17	4,539.07	4,605.07	4,875.68	4,148.74	4,487.45	3,648.46	3,405.85	3,340.76	3,562.47	2,511.81	990.04	3,411.4	3,467.39	2,674.99	3,067.33	1,778.49	2,975.29	4,713.36	2,752.59	6,286.44	3,189.27	3,188.04	2,176.66	2,952.02	3,190.17	2,930.78	1,952.5	1,931.41	2,620.15	2,716.06	911.03	3,084.24	2,681.87	2,158.83	2,072.43	2,896.74	2,454.33	1,399.79	552.95	904.7
Operating Income Ratio Numbers are in millions	0.145	0.115	-0.126	0.102	0.143	0.127	0.158	0.17	0.105	0.094	0.187	0.145	0.156	0.172	0.15	0.154	0.158	0.126	0.127	0.129	0.11	0.039	0.136	0.137	0.126	0.136	0.082	0.134	0.202	0.114	0.255	0.147	0.169	0.095	0.167	0.168	0.178	0.111	0.114	0.157	0.184	0.056	0.193	0.183	0.174	0.155	0.21	0.196	0.135	0.052	0.088
Total Other Income Expenses Net Numbers are in millions	-80.9	1,778.22	-2,110.68	-4,468.81	-1,431.55	-9,089.88	-633.88	-830.72	1,231.66	-91.78	-2,450.75	-689.46	-169.55	-1,500.5	-669.02	-1,093.7	-72.36	-226.26	-630.95	-89.46	-913.46	1,351.5	-1,975.77	2,219.17	592.04	-743.88	-383.17	-366.94	-372.53	-2,966.6	103.18	-119.44	168.04	-298.79	-328.35	-284.18	-290.87	-2,047.47	-421.31	-418.56	-389.95	-458.17	-467.42	-480.83	-460.79	-328.43	-399.92	-379.98	-377.81	1,042.1	-359.41
Income Before Tax Numbers are in millions	4,623.34	5,308.28	-5,213.81	-1,243.53	3,334.07	-4,907.66	4,709.96	4,802.11	4,080.12	2,696.91	3,430.42	3,849.61	4,435.52	3,375.18	3,479.72	3,393.75	3,576.1	3,179.59	2,709.81	3,473.01	1,598.35	2,341.54	1,435.63	5,686.56	3,267.03	2,323.45	1,395.32	2,608.35	4,340.83	-214.01	6,389.62	3,069.83	3,356.08	1,877.87	2,623.67	2,905.99	2,639.91	-94.97	1,510.1	2,201.59	2,326.11	452.86	2,616.82	2,201.04	1,698.04	1,744	2,496.82	2,074.35	1,021.98	1,595.05	545.29
Income Before Tax Ratio Numbers are in millions	0.143	0.173	-0.212	-0.039	0.1	-0.149	0.139	0.145	0.15	0.091	0.109	0.123	0.151	0.119	0.126	0.117	0.155	0.117	0.103	0.126	0.07	0.093	0.057	0.224	0.153	0.103	0.064	0.117	0.186	-0.009	0.259	0.141	0.178	0.082	0.149	0.153	0.161	-0.005	0.089	0.132	0.157	0.028	0.163	0.15	0.137	0.131	0.181	0.165	0.098	0.15	0.053
Income Tax Expense Numbers are in millions	1,220.96	17,694.73	-718.01	559.46	1,602.79	-876.3	1,802.34	2,015.42	1,969.05	971.25	1,032.91	1,101.56	1,370.25	1,036.44	997.93	1,053.82	1,035.68	976.51	801.42	917.59	505.54	778.57	358.96	1,637.29	937.13	813.08	460.74	565.24	1,086.06	-425.41	1,791.65	876.38	1,174.94	448.16	921.12	928.59	730.53	-200.82	362.5	551.1	477.14	18.72	473.51	628.01	392.49	45.65	366.34	477.1	218.06	72.79	84.11
Net Income Numbers are in millions	3,402.67	-12,182.79	-3,513.74	-819.45	1,499.31	-4,283.02	2,725.79	2,604.4	1,925.3	1,555.85	2,219.02	2,576.6	3,065.64	2,338.74	2,480.96	2,340.36	2,540.42	2,203.08	1,908.39	2,555.42	1,092.81	1,562.86	1,163.41	4,140	2,329.9	1,510.37	934.58	2,043.11	3,333.81	211.4	4,597.97	2,193.45	2,181.14	1,430.3	1,702.99	1,977.82	1,909.7	106.13	1,147.73	1,650.98	1,848.46	430.66	2,162.36	1,542.97	1,286.76	1,667.99	2,129.17	1,567.52	782.75	1,503.55	448.24
Net Income Ratio Numbers are in millions	0.105	-0.398	-0.143	-0.026	0.045	-0.13	0.08	0.079	0.071	0.053	0.071	0.082	0.104	0.083	0.09	0.08	0.11	0.081	0.072	0.092	0.048	0.062	0.046	0.163	0.109	0.067	0.043	0.092	0.143	0.009	0.187	0.101	0.116	0.062	0.097	0.104	0.116	0.006	0.068	0.099	0.125	0.027	0.135	0.105	0.104	0.125	0.154	0.125	0.075	0.141	0.043
EPS Numbers are in millions	12.06	-43.17	-12.45	-2.9	5.31	-15.18	9.66	9.23	6.82	5.51	7.86	9.13	10.86	8.29	8.8	8.29	9	7.81	6.76	9.06	3.87	5.54	4.12	14.67	8.26	5.35	3.31	7.24	11.81	0.75	16.29	7.77	7.73	5.07	6.95	7.66	6.91	0.39	4.23	6.09	6.82	1.53	7.98	5.69	4.75	5.91	7.86	5.79	2.89	5.47	1.66
EPS Diluted Numbers are in millions	12.06	-43.17	-12.45	-2.9	5.31	-15.18	9.66	9.23	6.82	5.51	7.86	9.13	10.86	8.29	8.8	8.29	9	7.81	6.76	9.06	3.87	5.54	4.12	14.67	8.26	5.35	3.31	7.24	11.81	0.75	16.29	7.77	7.73	5.07	6.95	7.66	6.91	0.39	4.23	6.09	6.81	1.53	7.97	5.69	4.75	5.91	7.86	5.79	2.89	5.47	1.66
EBITDA Numbers are in millions	5,882.13	5,043.43	-1,632.38	4,639.82	6,520.86	5,647.54	6,966.59	7,189.89	6,147.56	5,770.66	7,070.47	5,770.97	6,322.28	5,315.67	5,451.62	5,209.32	5,365.82	5,110.05	4,730.38	5,312.33	3,435.81	4,026.16	3,256.56	5,799.68	4,850.99	3,961.57	2,995.24	4,180.84	5,926.65	3,925.56	7,795.43	4,469.02	4,549.89	3,133.51	3,718.99	4,025.7	3,649.5	2,817.33	2,677.86	3,361.92	3,457.92	1,520.08	3,700.54	3,290.85	2,511.18	2,497.96	3,253.13	2,779	1,677.26	2,195.24	1,136.14
EBITDA Ratio Numbers are in millions	0.181	0.165	-0.066	0.147	0.195	0.171	0.205	0.217	0.226	0.195	0.225	0.185	0.215	0.188	0.198	0.179	0.232	0.188	0.179	0.192	0.15	0.159	0.13	0.228	0.228	0.176	0.138	0.188	0.254	0.162	0.317	0.206	0.242	0.137	0.211	0.212	0.222	0.161	0.158	0.201	0.234	0.094	0.231	0.225	0.203	0.187	0.236	0.221	0.161	0.206	0.11

Glenmark Pharmaceuticals Limited

NSE:GLENMARK.NS Add to watchlist

NSE:GLENMARK.NS